Durham, NC, United States of America

Patrick Reed Maloney


Average Co-Inventor Count = 5.3

ph-index = 5

Forward Citations = 157(Granted Patents)


Company Filing History:


Years Active: 1996-2008

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Patrick Reed Maloney

Introduction

Patrick Reed Maloney is a notable inventor based in Durham, NC (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of seven patents to his name, Maloney has made strides in developing innovative compounds and methods that have the potential to impact medical science.

Latest Patents

Among his latest patents, Maloney has developed Farnesoid X receptor agonists, which relate to a compound of formula (I). This invention includes pharmaceutical compositions, methods of using, and processes for preparing the same. Additionally, he has worked on the use of FXR ligands, which encompasses nuclear receptor heterodimer and nuclear receptor-coactivator peptide assays for identifying ligands for nuclear receptors. This work utilizes scintillation proximity and fluorescence resonance energy transfer (FRET) and outlines methods for using the identified ligands.

Career Highlights

Throughout his career, Maloney has been associated with prominent companies such as SmithKline Beecham Corporation and Glaxo Wellcome Inc. His work in these organizations has allowed him to contribute to significant advancements in pharmaceutical research and development.

Collaborations

Maloney has collaborated with notable coworkers, including Curt Dale Haffner and Timothy Mark Willson. These partnerships have further enriched his research and innovation efforts.

Conclusion

Patrick Reed Maloney's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations highlight his commitment to advancing medical science through inventive solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…